DOJ withdraws demand for Los Angeles hospital to turn over transgender minors’ records
Jan 23 (Reuters) – The U.S. Department of Justice has agreed to withdraw a subpoena demand that Children’s…
Many patients may keep off lost pounds after stopping a GLP-1, US data suggests
Real-world data suggests weight loss durability post-GLP-1 drug discontinuationStudy suggests weight regain may be less common than clinical…
Renewables push China’s fossil‑fuelled power into first annual drop in 10 years
BEIJING, Jan 19 (Reuters) – China’s mostly coal-based thermal power generation fell in 2025 for the first time…
Trump housing plan to allow 401(k) money for down payments, adviser says
WASHINGTON, Jan 16 (Reuters) – The Trump administration plans to allow investors to use some of their retirement…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalledTzield pushed back after adverse event…
US FDA requests removal of suicide warnings from weight-loss drug labels
Jan 13 (Reuters) – The U.S. health regulator asked drugmakers on Tuesday to remove label warnings about a…
China urges industrial parks to use more on-site green power
BEIJING, Jan 9 (Reuters) – China is pushing industrial parks to use more of their green power on-site…
US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Dec 30 (Reuters) – Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention…